Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients.

NCT01131065 is registered in ClinicalTrials.gov with Instituto Grifols, S.A. as lead sponsor.

NCT NCT01131065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01131065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients.
Lead sponsor
Instituto Grifols, S.A.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2010
Completion date
June 30, 2014
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, liver transplantation